IP Library › Granted Patent US 8,530,455
Granted Patent B2
US 8,530,455 · App. 12/851,041 · Granted Sep 10, 2013

Hemostatic effects of glucono-delta-lactone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,530,455
App. No.
12/851,041
Granted
Sep 10, 2013
Kind
B2
Abstract

Glucono-delta-lactone (GDL) can be used to mediate the human blood coagulation process. In particular, GDL can be used in an assay to determine an individual's risk potential for accelerated blood clotting or as a treatment for conditions related to accelerated clotting potential and/or inflammatory states.

Claims (1)

1. A method of lessening the coagulation properties of a patient's blood which comprises administering to a patient in need of anticoagulant therapy an anticoagulant effective amount of glucono-delta-lactone and lessening the coagulation properties of the patient's blood.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2015
From: RUTGERS UNIVERSITY
To: SPILLERT, CHARLES R.
Reel/Frame 036299/0614 →
NUNC PRO TUNC ASSIGNMENT Recorded Sep 5, 2013
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 031170/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2011
From: SPILLERT, CHARLES R.; PERSAUD, DEBBIE
To: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Reel/Frame 026307/0857 →